Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

Université de Montréal

$60,000.00

Exploring emerging chemical space for accelerated drug discovery

FY 2023-24

Summary
In this project titled Exploring Emerging Chemical Space for Accelerated Drug Discovery, three organicchemistry professors from UdeM (Cecioni, Lebel, Collins) are joining forces with Paraza Pharma, Inc. to accelerate drug discovery through the development of novel technologies for chemical synthesis. We arewill investigate new ways to construct innovative 3D-rich chemical architectures. At the molecular level, the shape and atom composition of molecules controls their interaction with biological targets, ultimately driving potential therapeutic benefits. Traditionally, medicinal chemists assemble building blocks that are composed ofmostly flat molecular parts. Our objective is to discover new chemical reactions that enable easy preparation ofmore complex 3D structures. Expanding our reach into such diverse chemical matter will develop unique Canadian expertise in the pharmaceutical sector through accelerated discovery, reduced costs via sustainable chemical methods, training of needed highly qualified personnel and perhaps ultimately, development of new therapeutic agents.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
586349-2023
Name nom
Cecioni, Samy S
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
60000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Organic syntheses
Research subject en
Chimie organique
Research subject fr
Synthèses organiques
Application title
Exploring emerging chemical space for accelerated drug discovery
Keyword
Catalysis; Glycochemistry; Heterocyclic chemistry; Late-stage functionalization; Medicinal chemistry; Non-classical bioisosteres; Organic Chemistry; Photochemistry; Sustainable chemistry; Synthetic methodology
Application summary
In this project titled Exploring Emerging Chemical Space for Accelerated Drug Discovery, three organicchemistry professors from UdeM (Cecioni, Lebel, Collins) are joining forces with Paraza Pharma, Inc. to accelerate drug discovery through the development of novel technologies for chemical synthesis. We arewill investigate new ways to construct innovative 3D-rich chemical architectures. At the molecular level, the shape and atom composition of molecules controls their interaction with biological targets, ultimately driving potential therapeutic benefits. Traditionally, medicinal chemists assemble building blocks that are composed ofmostly flat molecular parts. Our objective is to discover new chemical reactions that enable easy preparation ofmore complex 3D structures. Expanding our reach into such diverse chemical matter will develop unique Canadian expertise in the pharmaceutical sector through accelerated discovery, reduced costs via sustainable chemical methods, training of needed highly qualified personnel and perhaps ultimately, development of new therapeutic agents.
Université de Montréal - $60,000 Grant (2023-24) | Canada Spends